BTG plc announced a collaboration with the Society of Interventional Oncology, a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology.
Perthera Inc. announced its partnership with Hope for Stomach Cancer, a patient-focused nonprofit that provides support, resources, and awareness to those facing stomach cancer. Perthera's Precision Cancer Analysis service will be available to all Hope for Stomach Cancer patients at no cost to them.
RPRD Diagnostics announced a collaboration with Children's Minnesota dedicated to implementing a pharmaco-genomic testing process.
Jeffery Kutok was named chief scientific officer at Infinity Pharmaceuticals.
The CEO Roundtable on Cancer accredited CVS Health with the CEO Cancer Gold Standard, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
Cancer Research UK said four international teams are the first recipients of its global £100 million Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.
Sandra Horning, chief medical officer and executive vice president of global development at Roche/Genentech, will be presented with the 2017 Duane Roth Memorial Award on Feb. 16 at the annual Industry/Academia Translational Oncology Symposium at the UC San Diego Moores Cancer Center.
Yuan Chang and Patrick Moore, researchers at the University of Pittsburgh Cancer Institute, have been awarded the 2017 Paul Ehrlich and Ludwig Darmstaedter Prize.
The European Society for Medical Oncology announced the creation of a new award honoring individuals for achievements in cancer immunotherapy. The award will be presented at ESMO's newly launched Immuno-Oncology Congress in Geneva this December.
Jupiter Medical Center said it will adopt IBM's Watson for Oncology trained by Memorial Sloan Kettering Cancer Center, which will go live at the beginning of March.
